Search Results - "Yildirim Ozdemir, N"

Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity by Sendur, M A N, Aksoy, S, Yaman, S, Arik, Z, Tugba Kos, F, Akinci, M B, Civelek, B, Yildirim Ozdemir, N, Uncu, D, Zengin, N

“…There is a clinical need to predict the probability of cisplatin-induced nephrotoxicity (CIN) in order to make decisions about patient management and relevant…”
Get more information

Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients by Arslan, U Y, Turker, I, Aksoy, S, Oksuzoglu, B, Helvaci, K, Yildirim Ozdemir, N, Uyeturk, U, Uysal Sonmez, O, Budakoglu, B, Zengin, N

“…The duration of anti-HER2 blockage therapy in metastatic breast cancer patients is still unclear. We aimed to evaluate the effect of the anti-HER2 blockage…”
Get more information

6527 The efficacy of modified docetaxel, cisplatin and 5-fluorouracil in advanced stage gastric carcinoma by Yildirim, N. Ozdemir, Abali, H, Oksuzoglu, B, Budakoglu, B, Uncu, D, Guler, T, Odabasi, H, Cihan, S, Zengin, N

Get full text

1835P Effect of serum uric acid (ua) level and MASCC risk score on febrile neutropenia mortality by Sutcuoglu, O., Akdogan, O., Kurt Inci, B., Gürler, F., Özdemir Yıldırım, N., Yazıcı, O.

Get full text

1828P Effect of serum albumin/globulin ratio in combination with MASCC and CISNE risk score on febrile neutropenia mortality by Yazıcı, O., Sutcuoglu, O., Akdogan, O., Kurt Inci, B., Gürler, F., Özdemir Yıldırım, N.

Get full text

1473P Parameters of complete blood count might predict the prognosis of patients with advanced gastric cancer by Sutcuoglu, O., Fincan, A., Gürler, F., Kurt Inci, B., Özdemir Yıldırım, N., Yazıcı, O.

Get full text